Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuichiro Ito

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 24, 2016
Little Impact on Renal Function in Advanced Renal Cell Carcinoma Patients Treated with Sorafenib--Analyses of Postmarketing Surveillance in Japan in over 3,200 Consecutive CasesMototsugu Oya, Katsunori Tatsugami, Koki Kabu, et al.
World Journal of Gastroenterology|May 1, 2007
Solitary recurrence of hilar cholangiocarcinoma in a mediastinal lymph node two years after curative resectionYuichiro Ito, Yoshitsugu Tajima, Fumihiko Fujita, et al.
Patient Preference and Adherence|August 5, 2024
Physician and Patient Preferences for Treatment of Anemia Associated with Chronic Kidney Disease in Japan: A Survey Including Best-Worst ScalingSari Mishina, Yuichiro Ito, Takumi Lee, et al.
Journal of Diabetes Investigation|October 30, 2024
Retrospective database study on risk factors for diabetic retinopathy and diabetic kidney disease in Japanese patients with diabetes mellitusKota Yamada, Mitsuru Ohsugi, Yuichiro Ito, et al.
Nephrology (Carlton, Vic.)|May 10, 2023
A retrospective database analysis of erythropoiesis-stimulating agent treatment patterns and associated healthcare resource use in patients with non-dialysis-dependent chronic kidney disease-related anaemia in JapanSari Mishina, Miina Waratani, Satoshi Onozawa, et al.
Journal of Diabetes Investigation|March 4, 2022
Reduction in cardiovascular disease events in patients with type 2 diabetes mellitus treated with a sodium-glucose cotransporter 2 inhibitor versus a dipeptidyl peptidase-4 inhibitor: A real-world retrospective administrative database analysis in JapanAtsunori Kashiwagi, Shingo Shoji, Satoshi Onozawa, et al.
International Surgery|May 20, 2010
MRI can determine the adequate area for debridement in the case of Fournier's gangreneAkira Yoneda, Fumihiko Fujita, Hirotaka Tokai, et al.
The Journal of Dermatology|July 27, 2022
Real-world safety and effectiveness of pembrolizumab in Japanese patients with radically unresectable melanoma: An all-case postmarketing surveillance in JapanNaoya Yamazaki, Akiko Shimizu, Masahiko Ozaki, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|February 7, 2009
The effect of eating on lower esophageal sphincter electrical activityClaudia P Sanmiguel, Yuichiro Ito, Masanobu Hagiike, et al.
International Journal of Clinical Oncology|April 29, 2025
Adverse events of hepatic function disorder in Japanese patients with radically unresectable or metastatic renal cell carcinoma treated with pembrolizumab plus axitinib: a post-marketing surveillance studyMototsugu Oya, Shotaro Yasuoka, Takuto Tokudome, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 24, 2016
Little Impact on Renal Function in Advanced Renal Cell Carcinoma Patients Treated with Sorafenib--Analyses of Postmarketing Surveillance in Japan in over 3,200 Consecutive CasesMototsugu Oya, Katsunori Tatsugami, Koki Kabu, et al.
World Journal of Gastroenterology|May 1, 2007
Solitary recurrence of hilar cholangiocarcinoma in a mediastinal lymph node two years after curative resectionYuichiro Ito, Yoshitsugu Tajima, Fumihiko Fujita, et al.
Patient Preference and Adherence|August 5, 2024
Physician and Patient Preferences for Treatment of Anemia Associated with Chronic Kidney Disease in Japan: A Survey Including Best-Worst ScalingSari Mishina, Yuichiro Ito, Takumi Lee, et al.
Journal of Diabetes Investigation|October 30, 2024
Retrospective database study on risk factors for diabetic retinopathy and diabetic kidney disease in Japanese patients with diabetes mellitusKota Yamada, Mitsuru Ohsugi, Yuichiro Ito, et al.
Nephrology (Carlton, Vic.)|May 10, 2023
A retrospective database analysis of erythropoiesis-stimulating agent treatment patterns and associated healthcare resource use in patients with non-dialysis-dependent chronic kidney disease-related anaemia in JapanSari Mishina, Miina Waratani, Satoshi Onozawa, et al.
Journal of Diabetes Investigation|March 4, 2022
Reduction in cardiovascular disease events in patients with type 2 diabetes mellitus treated with a sodium-glucose cotransporter 2 inhibitor versus a dipeptidyl peptidase-4 inhibitor: A real-world retrospective administrative database analysis in JapanAtsunori Kashiwagi, Shingo Shoji, Satoshi Onozawa, et al.
International Surgery|May 20, 2010
MRI can determine the adequate area for debridement in the case of Fournier's gangreneAkira Yoneda, Fumihiko Fujita, Hirotaka Tokai, et al.
The Journal of Dermatology|July 27, 2022
Real-world safety and effectiveness of pembrolizumab in Japanese patients with radically unresectable melanoma: An all-case postmarketing surveillance in JapanNaoya Yamazaki, Akiko Shimizu, Masahiko Ozaki, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|February 7, 2009
The effect of eating on lower esophageal sphincter electrical activityClaudia P Sanmiguel, Yuichiro Ito, Masanobu Hagiike, et al.
International Journal of Clinical Oncology|April 29, 2025
Adverse events of hepatic function disorder in Japanese patients with radically unresectable or metastatic renal cell carcinoma treated with pembrolizumab plus axitinib: a post-marketing surveillance studyMototsugu Oya, Shotaro Yasuoka, Takuto Tokudome, et al.
Pageof 4